Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine

British Journal of Cancer

Volumn 107, Issue 8, 2012, Pages 1384-1391

  Saeb Parsy, K ^a   Wilson, A ^b   Scarpini, C ^c   Corcoran, M ^a   Chilcott, S ^a   McKean, M ^d   Thottakam, B ^e   Rai, B ^d   Nabi, G ^f   Rana, D ^g   Perera, M ^g   Stewart, K ^h   Laskey, R A ^c   Neal, D E ^a   Coleman, N ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^e Cytosystems Ltd   (United Kingdom)

^f Medical Education Institute   (United Kingdom)

^g MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Biomarker; Bladder cancer; Cytology; Immunocytochemistry; MCM 2; Urothelial carcinoma

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN 2;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMATURIA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; URINE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; HEMATURIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84867399397     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.381     Document Type: Article

References (31)

1. Baldwin P, Laskey R, Coleman N (2003) Translational approaches to improving cervical screening. Nat Rev Cancer 3: 217-226 (Pubitemid 37328873)
2. Budman LI, Kassouf W, Steinberg JR (2008) Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J 2: 212-221
3. Chatrath P, Scott IS, Morris LS, Davies RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D, Laskey RA, Coleman N (2003) Aberrant expression of minichromosome maintenance protein- 2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer 89: 1048-1054 (Pubitemid 37239210)
4. Davies RJ, Freeman A, Morris LS, Bingham S, Dilworth S, Scott I, Laskey RA, Miller R, Coleman N (2002) Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359: 1917-1919 (Pubitemid 34615772)
5. Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH, Coleman N (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5: 2121-2132 (Pubitemid 29399268)
6. Gonzalez MA, Tachibana KE, Laskey RA, Coleman N (2005) Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer 5: 135-141 (Pubitemid 40215861)
7. Halling KC, Kipp BR (2008) Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol 15: 279-286
8. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086 (Pubitemid 14207227)
9. Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF (2008) Urinebased biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 60: 217-235
10. Herr HW (1999) The natural history of a T1 bladder cancer: life-long tumour diathesis. BJU Int 84: 1102-1103
11. Hwang EC, Choi HS, Jung SI, Kwon DD, Park K, Ryu SB, Use of the NMP22 (2011) BladderChek test in the diagnosis and follow-up of urothelial cancer: a cross-sectional study. Urology 77: 154-159
12. Karakiewicz PI, Benayoun S, Zippe C, Ludecke G, Boman H, Sanchezcarbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF (2006) Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97: 997-1001
13. Kearsey SE, Labib K (1998) MCM proteins: evolution, properties, and role in DNA replication. Biochem Biophys Acta 1398: 113-136 (Pubitemid 28305206)
14. Kearsey SE, Maiorano D, Holmes EC, Todorov IT (1996) The role of MCM proteins in the cell cycle control of genome duplication. Bioessays 18: 183-190
15. Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-tsagli E, Patsouris E (2005) Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol 36: 899-907 (Pubitemid 41187909)
16. Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers vs cytology: results of a comprehensive literature review and meta-analyses. Urology 61: 109-118; discussion 118 (Pubitemid 36151724)
17. Madine MA, Swietlik M, Pelizon C, Romanowski P, Mills AD, Laskey RA (2000) The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. J Struct Biol 129: 198-210 (Pubitemid 30481360)
18. Maiorano D, Van Assendelft GB, Kearsey SE (1996) Fission yeast cdc21, a member of the MCM protein family, is required for onset of S phase and is located in the nucleus throughout the cell cycle. EMBO J 15: 861-872 (Pubitemid 26064292)
19. Musahl C, Holthoff HP, Lesch R, Knippers R (1998) Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 241: 260-264 (Pubitemid 28366601)
20. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45-50
21. Prout JR GR, Barton BA, Griffin PP, Friedell GH (1992) Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J Urol 148: 1413-1419
22. Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, Duffy S, Ritchie G, Kleijnen J, Westwood M (2006) Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technol Assess 10: iii-iv, xi-259
23. Rubben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G (1988) Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139: 283-285
24. Scarpini C, White V, Muralidhar B, Patterson A, Hickey N, Singh N, Mullerat J, Winslet M, Davies RJ, Phillips ML, Stacey P, Laskey RA, Miller R, Nathan M, Coleman N (2008) Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins. Cancer Epidemiol Biomarkers Prev 17: 2855-2864
25. Sirieix PS, O'donovan M, Brown J, Save V, Coleman N, Fitzgerald RC (2003) Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. Clin Cancer Res 9: 2560-2566 (Pubitemid 36842097)
26. Stoeber K, Halsall I, Freeman A, Swinn R, Doble A, Morris L, Coleman N, Bullock N, Laskey RA, Hales CN, Williams GH (1999) Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet 354: 1524-1525 (Pubitemid 29502109)
27. Stoeber K, Swinn R, Prevost AT, De Clive-lowe P, Halsall I, Dilworth SM, Marr J, Turner WH, Bullock N, Doble A, Hales CN, Williams GH (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 94: 1071-1079 (Pubitemid 34830727)
28. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, Williams ED, Williams GH (2001) DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041 (Pubitemid 32586628)
29. van der Poel HG, Debruyne FM (2001) Can biological markers replace cystoscopy? An update. Curr Opin Urol 11: 503-509 (Pubitemid 32783698)
30. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, Marr J, Laskey RA, Coleman N (1998) Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 95: 14932-14937 (Pubitemid 29003734)
31. Yutkin V, Nisman B, Pode D (2010) Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance? Expert Rev Anticancer Ther 10: 787-790